Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 116 entries
Sorted by: Best Match Show Resources per page
Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?.

Korean journal of family medicine

Sandoughi M, Fazeli SA, Naseri-Ramroudi F, Barzkar F.
PMID: 29972895
Korean J Fam Med. 2018 Sep;39(5):318-321. doi: 10.4082/kjfm.17.0118. Epub 2018 Jul 04.

The management of prolonged fever in low-socioeconomic-status areas by primary care providers such as general practitioners is challenging. Given the endemic nature of many infectious diseases, physicians typically start empirical antibiotic therapy following a limited diagnostic workup including serologic...

Cite
Sandoughi M, Fazeli SA, Naseri-Ramroudi F, et al. Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?. Korean J Fam Med. 2018;39(5):318-321doi: 10.4082/kjfm.17.0118.
Sandoughi, M., Fazeli, S. A., Naseri-Ramroudi, F., & Barzkar, F. (2018). Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?. Korean journal of family medicine, 39(5), 318-321. https://doi.org/10.4082/kjfm.17.0118
Sandoughi, Mahnaz, et al. "Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?." Korean journal of family medicine vol. 39,5 (2018): 318-321. doi: https://doi.org/10.4082/kjfm.17.0118
Sandoughi M, Fazeli SA, Naseri-Ramroudi F, Barzkar F. Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?. Korean J Fam Med. 2018 Sep;39(5):318-321. doi: 10.4082/kjfm.17.0118. Epub 2018 Jul 04. PMID: 29972895; PMCID: PMC6166114.
Copy Download .nbib Format: NLM
Yield, chemical composition, fermentation characteristics, in vitro ruminal variables, and degradability of ensiled amaranth (.

Translational animal science

Shadi H, Rouzbehan Y, Rezaei J, Fazaeli H.
PMID: 34164610
Transl Anim Sci. 2020 Oct 06;4(4):txaa180. doi: 10.1093/tas/txaa180. eCollection 2020 Oct.

Silages from four amaranth varieties (A5, A12, A14, and A28) were compared with corn silage (CS) in terms of their yield, chemical composition, phenolic compounds, oxalic acid and nitrate levels, silage fermentation characteristics, in vitro methane production, organic matter...

Cite
Shadi H, Rouzbehan Y, Rezaei J, et al. Yield, chemical composition, fermentation characteristics, in vitro ruminal variables, and degradability of ensiled amaranth (. Transl Anim Sci. 2020;4(4):txaa180doi: 10.1093/tas/txaa180.
Shadi, H., Rouzbehan, Y., Rezaei, J., & Fazaeli, H. (2020). Yield, chemical composition, fermentation characteristics, in vitro ruminal variables, and degradability of ensiled amaranth (. Translational animal science, 4(4), txaa180. https://doi.org/10.1093/tas/txaa180
Shadi, Hossein, et al. "Yield, chemical composition, fermentation characteristics, in vitro ruminal variables, and degradability of ensiled amaranth (." Translational animal science vol. 4,4 (2020): txaa180. doi: https://doi.org/10.1093/tas/txaa180
Shadi H, Rouzbehan Y, Rezaei J, Fazaeli H. Yield, chemical composition, fermentation characteristics, in vitro ruminal variables, and degradability of ensiled amaranth (. Transl Anim Sci. 2020 Oct 06;4(4):txaa180. doi: 10.1093/tas/txaa180. eCollection 2020 Oct. PMID: 34164610; PMCID: PMC8216493.
Copy Download .nbib Format: NLM
List Decoding of Arıkan's PAC Codes.

Entropy (Basel, Switzerland)

Yao H, Fazeli A, Vardy A.
PMID: 34209050
Entropy (Basel). 2021 Jun 30;23(7). doi: 10.3390/e23070841.

Polar coding gives rise to the first explicit family of codes that provably achieve capacity with efficient encoding and decoding for a wide range of channels. However, its performance at short blocklengths under standard successive cancellation decoding is far...

Cite
Yao H, Fazeli A, Vardy A. List Decoding of Arıkan's PAC Codes. Entropy (Basel). 2021;23(7)doi: 10.3390/e23070841.
Yao, H., Fazeli, A., & Vardy, A. (2021). List Decoding of Arıkan's PAC Codes. Entropy (Basel, Switzerland), 23(7), . https://doi.org/10.3390/e23070841
Yao, Hanwen, et al. "List Decoding of Arıkan's PAC Codes." Entropy (Basel, Switzerland) vol. 23,7 (2021). doi: https://doi.org/10.3390/e23070841
Yao H, Fazeli A, Vardy A. List Decoding of Arıkan's PAC Codes. Entropy (Basel). 2021 Jun 30;23(7). doi: 10.3390/e23070841. PMID: 34209050; PMCID: PMC8303677.
Copy Download .nbib Format: NLM
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer.

Cancer discovery

Fix SM, Jazaeri AA, Hwu P.
PMID: 33563662
Cancer Discov. 2021 Mar;11(3):560-574. doi: 10.1158/2159-8290.CD-20-1083. Epub 2021 Feb 09.

Adoptive cell therapy (ACT) for cancer shows tremendous potential; however, several challenges preclude its widespread use. These include poor T-cell function in hostile tumor microenvironments, a lack of tumor-specific target antigens, and the high cost and poor scalability of...

Cite
Fix SM, Jazaeri AA, Hwu P. Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer. Cancer Discov. 2021;11(3):560-574doi: 10.1158/2159-8290.CD-20-1083.
Fix, S. M., Jazaeri, A. A., & Hwu, P. (2021). Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer. Cancer discovery, 11(3), 560-574. https://doi.org/10.1158/2159-8290.CD-20-1083
Fix, Samantha M, et al. "Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer." Cancer discovery vol. 11,3 (2021): 560-574. doi: https://doi.org/10.1158/2159-8290.CD-20-1083
Fix SM, Jazaeri AA, Hwu P. Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer. Cancer Discov. 2021 Mar;11(3):560-574. doi: 10.1158/2159-8290.CD-20-1083. Epub 2021 Feb 09. PMID: 33563662; PMCID: PMC8193798.
Copy Download .nbib Format: NLM
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Fazeli A, Sharifi S, Behdad F, Okati S, Esmaielifar G, Jelveh N, Eshghi P, Mohammadi S.
PMID: 34836825
Transfus Apher Sci. 2021 Nov 23;103321. doi: 10.1016/j.transci.2021.103321. Epub 2021 Nov 23.

BACKGROUND AND OBJECTIVES: The use of COVID-19 convalescent plasma (CCP) has been approved by the FDA. We assessed the outcome of patients with moderate and severe COVID-19 following convalescent plasma therapy and the association with variables such as antibody...

Cite
Fazeli A, Sharifi S, Behdad F, et al. Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19. Transfus Apher Sci. 2021;103321doi: 10.1016/j.transci.2021.103321.
Fazeli, A., Sharifi, S., Behdad, F., Okati, S., Esmaielifar, G., Jelveh, N., Eshghi, P., & Mohammadi, S. (2021). Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 103321. https://doi.org/10.1016/j.transci.2021.103321
Fazeli, Alieh, et al. "Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis vol. (2021): 103321. doi: https://doi.org/10.1016/j.transci.2021.103321
Fazeli A, Sharifi S, Behdad F, Okati S, Esmaielifar G, Jelveh N, Eshghi P, Mohammadi S. Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19. Transfus Apher Sci. 2021 Nov 23;103321. doi: 10.1016/j.transci.2021.103321. Epub 2021 Nov 23. PMID: 34836825; PMCID: PMC8612443.
Copy Download .nbib Format: NLM
A Modified Approach for Single-Port Laparoscopic Repair of Inguinal Hernias in Children.

Advanced biomedical research

Fazeli A, Davari HA, Hosseinpour M.
PMID: 33457346
Adv Biomed Res. 2020 Oct 30;9:63. doi: 10.4103/abr.abr_80_20. eCollection 2020.

BACKGROUND: Although traditional open groin incision repair has been used routinely for decades, the benefit of the minimally invasive surgery has challenged the traditional open method. Nowadays, laparoscopic herniorraphy has evolved to making it more minimally invasive from 3...

Cite
Fazeli A, Davari HA, Hosseinpour M. A Modified Approach for Single-Port Laparoscopic Repair of Inguinal Hernias in Children. Adv Biomed Res. 2020;9:63doi: 10.4103/abr.abr_80_20.
Fazeli, A., Davari, H. A., & Hosseinpour, M. (2020). A Modified Approach for Single-Port Laparoscopic Repair of Inguinal Hernias in Children. Advanced biomedical research, 963. https://doi.org/10.4103/abr.abr_80_20
Fazeli, Ali, et al. "A Modified Approach for Single-Port Laparoscopic Repair of Inguinal Hernias in Children." Advanced biomedical research vol. 9 (2020): 63. doi: https://doi.org/10.4103/abr.abr_80_20
Fazeli A, Davari HA, Hosseinpour M. A Modified Approach for Single-Port Laparoscopic Repair of Inguinal Hernias in Children. Adv Biomed Res. 2020 Oct 30;9:63. doi: 10.4103/abr.abr_80_20. eCollection 2020. PMID: 33457346; PMCID: PMC7792869.
Copy Download .nbib Format: NLM
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.

Gynecologic oncology

How JA, Patel S, Fellman B, Lu KH, Hwu P, Ramondetta LM, Westin SN, Fleming ND, Soliman PT, Jazaeri AA.
PMID: 33958211
Gynecol Oncol. 2021 Jul;162(1):24-31. doi: 10.1016/j.ygyno.2021.04.034. Epub 2021 May 03.

OBJECTIVE: We reviewed our institutional data to evaluate toxicity and efficacy outcomes of pembrolizumab/lenvatinib in recurrent endometrial cancer in a "real-world" clinical setting and to compare the impact of reduced lenvatinib starting dose on outcomes.METHODS: Retrospectively, we reviewed toxicity,...

Cite
How JA, Patel S, Fellman B, et al. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecol Oncol. 2021;162(1):24-31doi: 10.1016/j.ygyno.2021.04.034.
How, J. A., Patel, S., Fellman, B., Lu, K. H., Hwu, P., Ramondetta, L. M., Westin, S. N., Fleming, N. D., Soliman, P. T., & Jazaeri, A. A. (2021). Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecologic oncology, 162(1), 24-31. https://doi.org/10.1016/j.ygyno.2021.04.034
How, Jeffrey A, et al. "Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer." Gynecologic oncology vol. 162,1 (2021): 24-31. doi: https://doi.org/10.1016/j.ygyno.2021.04.034
How JA, Patel S, Fellman B, Lu KH, Hwu P, Ramondetta LM, Westin SN, Fleming ND, Soliman PT, Jazaeri AA. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecol Oncol. 2021 Jul;162(1):24-31. doi: 10.1016/j.ygyno.2021.04.034. Epub 2021 May 03. PMID: 33958211; PMCID: PMC8222164.
Copy Download .nbib Format: NLM
FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in .

Iranian journal of pharmaceutical research : IJPR

Naeimipour S, Shojaosadati SA, Fazeli A.
PMID: 33224222
Iran J Pharm Res. 2020;19(2):175-181. doi: 10.22037/ijpr.2020.1101092.

Recent studies suggest that reducing the induction temperature would improve the quality of some recombinant inclusion bodies (IB) by providing a native-like secondary structure and leading to an improvement in protein recovery. This study focused on optimizing the solubilization...

Cite
Naeimipour S, Shojaosadati SA, Fazeli A. FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in . Iran J Pharm Res. 2020;19(2):175-181doi: 10.22037/ijpr.2020.1101092.
Naeimipour, S., Shojaosadati, S. A., & Fazeli, A. (2020). FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in . Iranian journal of pharmaceutical research : IJPR, 19(2), 175-181. https://doi.org/10.22037/ijpr.2020.1101092
Naeimipour, Sajjad, et al. "FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in ." Iranian journal of pharmaceutical research : IJPR vol. 19,2 (2020): 175-181. doi: https://doi.org/10.22037/ijpr.2020.1101092
Naeimipour S, Shojaosadati SA, Fazeli A. FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in . Iran J Pharm Res. 2020;19(2):175-181. doi: 10.22037/ijpr.2020.1101092. PMID: 33224222; PMCID: PMC7667556.
Copy Download .nbib Format: NLM
Colostrum and milk performance, and blood immunity indices and minerals of Holstein cows receiving organic Mn, Zn and Cu sources.

Animal nutrition (Zhongguo xu mu shou yi xue hui)

Roshanzamir H, Rezaei J, Fazaeli H.
PMID: 32211530
Anim Nutr. 2020 Mar;6(1):61-68. doi: 10.1016/j.aninu.2019.08.003. Epub 2019 Oct 23.

Effects of supplementing the basal diets with Mn, Zn and Cu, as sulphate, glycine or methionine salts, on colostrum and milk performance, some blood immunity indices and blood minerals of pre- and post-partum Holstein cows were accessed. Forty cows...

Cite
Roshanzamir H, Rezaei J, Fazaeli H. Colostrum and milk performance, and blood immunity indices and minerals of Holstein cows receiving organic Mn, Zn and Cu sources. Anim Nutr. 2019;6(1):61-68doi: 10.1016/j.aninu.2019.08.003.
Roshanzamir, H., Rezaei, J., & Fazaeli, H. (2020). Colostrum and milk performance, and blood immunity indices and minerals of Holstein cows receiving organic Mn, Zn and Cu sources. Animal nutrition (Zhongguo xu mu shou yi xue hui), 6(1), 61-68. https://doi.org/10.1016/j.aninu.2019.08.003
Roshanzamir, Habiballah, et al. "Colostrum and milk performance, and blood immunity indices and minerals of Holstein cows receiving organic Mn, Zn and Cu sources." Animal nutrition (Zhongguo xu mu shou yi xue hui) vol. 6,1 (2020): 61-68. doi: https://doi.org/10.1016/j.aninu.2019.08.003
Roshanzamir H, Rezaei J, Fazaeli H. Colostrum and milk performance, and blood immunity indices and minerals of Holstein cows receiving organic Mn, Zn and Cu sources. Anim Nutr. 2020 Mar;6(1):61-68. doi: 10.1016/j.aninu.2019.08.003. Epub 2019 Oct 23. PMID: 32211530; PMCID: PMC7083722.
Copy Download .nbib Format: NLM
Development, Implementation, and User Evaluation of COVID-19 Dashboard in a Third-Level Hospital in Iran.

Applied clinical informatics

Fazaeli S, Khodaveisi T, Vakilzadeh AK, Yousefi M, Ariafar A, Shokoohizadeh M, Mohammad-Pour S.
PMID: 34879405
Appl Clin Inform. 2021 Oct;12(5):1091-1100. doi: 10.1055/s-0041-1740188. Epub 2021 Dec 08.

INTRODUCTION: The implementation of a dashboard enables managers to make informed and evidence-based decisions through data visualization and graphical presentation of information. This study aimed to design and implement a COVID-19 management dashboard in a third-level hospital in Mashhad,...

Cite
Fazaeli S, Khodaveisi T, Vakilzadeh AK, et al. Development, Implementation, and User Evaluation of COVID-19 Dashboard in a Third-Level Hospital in Iran. Appl Clin Inform. 2021;12(5):1091-1100doi: 10.1055/s-0041-1740188.
Fazaeli, S., Khodaveisi, T., Vakilzadeh, A. K., Yousefi, M., Ariafar, A., Shokoohizadeh, M., & Mohammad-Pour, S. (2021). Development, Implementation, and User Evaluation of COVID-19 Dashboard in a Third-Level Hospital in Iran. Applied clinical informatics, 12(5), 1091-1100. https://doi.org/10.1055/s-0041-1740188
Fazaeli, Somayeh, et al. "Development, Implementation, and User Evaluation of COVID-19 Dashboard in a Third-Level Hospital in Iran." Applied clinical informatics vol. 12,5 (2021): 1091-1100. doi: https://doi.org/10.1055/s-0041-1740188
Fazaeli S, Khodaveisi T, Vakilzadeh AK, Yousefi M, Ariafar A, Shokoohizadeh M, Mohammad-Pour S. Development, Implementation, and User Evaluation of COVID-19 Dashboard in a Third-Level Hospital in Iran. Appl Clin Inform. 2021 Oct;12(5):1091-1100. doi: 10.1055/s-0041-1740188. Epub 2021 Dec 08. PMID: 34879405; PMCID: PMC8654579.
Copy Download .nbib Format: NLM
Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF).

Reproductive biology

Basatvat S, Russell JM, Saare M, Thurston LM, Salumets A, Fazeli A.
PMID: 34808454
Reprod Biol. 2021 Dec;21(4):100569. doi: 10.1016/j.repbio.2021.100569. Epub 2021 Nov 19.

The successful implantation of the embryo into a receptive endometrium is essential for the establishment of a viable pregnancy while recurrent implantation failure (RIF) is a real challenge in assisted reproduction. The maternal innate immune system, specifically the Toll-like...

Cite
Basatvat S, Russell JM, Saare M, et al. Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF). Reprod Biol. 2021;21(4):100569doi: 10.1016/j.repbio.2021.100569.
Basatvat, S., Russell, J. M., Saare, M., Thurston, L. M., Salumets, A., & Fazeli, A. (2021). Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF). Reproductive biology, 21(4), 100569. https://doi.org/10.1016/j.repbio.2021.100569
Basatvat, Shaghayegh, et al. "Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF)." Reproductive biology vol. 21,4 (2021): 100569. doi: https://doi.org/10.1016/j.repbio.2021.100569
Basatvat S, Russell JM, Saare M, Thurston LM, Salumets A, Fazeli A. Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF). Reprod Biol. 2021 Dec;21(4):100569. doi: 10.1016/j.repbio.2021.100569. Epub 2021 Nov 19. PMID: 34808454.
Copy Download .nbib Format: NLM
A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model.

BioMed research international

Fazaeli H, Kalhor N, Naserpour L, Davoodi F, Sheykhhasan M, Hosseini SKE, Rabiei M, Sheikholeslami A.
PMID: 34616850
Biomed Res Int. 2021 Sep 27;2021:9688138. doi: 10.1155/2021/9688138. eCollection 2021.

BACKGROUND: Exosomes as extracellular vesicles (EVs) are nanoscale intercellular messengers secreted from cells to deliver biological signals. Today, exosomes have become a new field of research in regenerative medicine and are considered as potential therapies to control inflammation and...

Cite
Fazaeli H, Kalhor N, Naserpour L, et al. A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model. Biomed Res Int. 2021;2021:9688138doi: 10.1155/2021/9688138.
Fazaeli, H., Kalhor, N., Naserpour, L., Davoodi, F., Sheykhhasan, M., Hosseini, S. K. E., Rabiei, M., & Sheikholeslami, A. (2021). A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model. BioMed research international, 20219688138. https://doi.org/10.1155/2021/9688138
Fazaeli, Hoda, et al. "A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model." BioMed research international vol. 2021 (2021): 9688138. doi: https://doi.org/10.1155/2021/9688138
Fazaeli H, Kalhor N, Naserpour L, Davoodi F, Sheykhhasan M, Hosseini SKE, Rabiei M, Sheikholeslami A. A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model. Biomed Res Int. 2021 Sep 27;2021:9688138. doi: 10.1155/2021/9688138. eCollection 2021. PMID: 34616850; PMCID: PMC8490078.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 116 entries